Agenus (AGEN) Announces Positive Efficacy Data from Glaxo (GSK) Second Shingles Vaccine Phase 3
Tweet Send to a Friend
Agenus (NASDAQ: AGEN) announced that GlaxoSmithKline’s plc (NYSE: GSK) second pivotal Phase III efficacy study of its shingles vaccine candidate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
